Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Operating Leases (2020 - 2025)

RxSight's Operating Leases history spans 6 years, with the latest figure at $9.9 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 12.75% year-over-year to $9.9 million; the TTM value through Dec 2025 reached $9.9 million, down 12.75%, while the annual FY2025 figure was $9.9 million, 12.75% down from the prior year.
  • Operating Leases reached $9.9 million in Q4 2025 per RXST's latest filing, down from $10.3 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $11.3 million in Q4 2024 to a low of $908000.0 in Q1 2024.
  • Average Operating Leases over 5 years is $5.7 million, with a median of $3.9 million recorded in 2022.
  • Peak YoY movement for Operating Leases: plummeted 61.16% in 2024, then skyrocketed 1110.02% in 2025.
  • A 5-year view of Operating Leases shows it stood at $3.6 million in 2021, then dropped by 21.58% to $2.9 million in 2022, then crashed by 57.6% to $1.2 million in 2023, then soared by 834.93% to $11.3 million in 2024, then fell by 12.75% to $9.9 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Operating Leases are $9.9 million (Q4 2025), $10.3 million (Q3 2025), and $10.6 million (Q2 2025).